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Abstract
Introduction. Recognition of severe acute pancreatitis (SAP), intensive care, shifting away from early surgical treatment, and
monitoring of the intra-abdominal pressure (IAP) is important in the management of SAP. The aim of our study was
retrospective evaluation and critical assessment of the experience with SAP management protocol involving new strategy in
the university hospital. Methods. Protocols of 274 SAP patients treated in our institution during the last eight years were
reassessed. Acute physiology and chronic health evaluation II (APACHE II), C-reactive protein (CRP) and Sequential
Organ Failure Assessment (SOFA) score, IAP, pulmonary complications, ventilatory support and infection rate were
evaluated. The success of the conservative treatment, surgical interventions and mortality was analysed comparing period 1
from 1999 to 2002 and period 2 from 2003 to 2006. Results. More patients with necrotising SAP were treated in period 2.
The average CRP and SOFA score was higher in period 2, p0.018; p0.011. A total of 139 patients underwent
continuous veno-venouse haemofiltration (CVVH) as a component of fluid resuscitation and IAP control. Application of
CVVH increased in period 2, pB0.005. Only 58% of patients were managed with ventilatory support. The overall
infection rate decreased in period 2 comprising 21%, pB0.005. Success rate of the conservative therapy reached 69% in
period 2, pB0.01. Surgical treatment was performed in 41% of patients in period 1 vs. 19% in period 2, pB0.001. Overall
mortality was 19%, with a reduction to 12% in year 2006. Conclusion. The conservative protocol-based approach is a
rational treatment strategy for the management of SAP and can be successfully implemented in the setting of the university
hospital.
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Introduction
Management of acute pancreatitis is a hot topic
through the recent decades. The basic treatment
strategy is highlighted in several international pub-
lications and generally recommends prompt recogni-
tion of severe forms, aggressive intensive care and a
shift away from early surgical treatment in necrotising
forms [1]. A considerable part of patients including
those with necrotising forms can be successfully
treated conservatively [2]. A more conservative ap-
proach gives opportunity to postpone surgical inter-
vention in necrotising forms in the major part of
patients on average after the third week from the onset
of the disease in cases when infection and sepsis are
not clinically manifest [3]. Formation of postnecrotic
pseudocysts is one possible form of outcome after in-
hospital treatment. Involvement of interventional
therapies during the early treatment course is ques-
tionable due to associated risk of nosocomial infection;
however, it could be rational when applied for the
initial control of sepsis for patients in poor condition.
This approach is associated with less dramatic sys-
temic response; at the same time, the clinical course
can later be associated with progression of systemic
inflammatory response syndrome (SIRS) and multi-
ple organ dysfunction syndrome (MODS) mainly as a
consequence of incomplete drainage of the solid
necrotic infected tissue [1,4]. The aim of our study
was retrospective evaluation and critical assessment of
the experience with implementation of severe acute
pancreatitis (SAP) management protocol involving
new strategy and treatment modalities available in
our university hospital.
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Methods
Protocols of patients who suffered SAP and were
treated in our institution during the time period
between year 1999 and 2006 were reassessed con-
sidering the implementation of more conservative
approach, early application of continuous veno-ve-
nouse haemofiltration (CVVH), early enteral feeding,
and control of the intra-abdominal hypertension
(IAH). Patients with malignancies were not included.
Diagnosis and severity assessment
Acute pancreatitis was diagnosed according to the
clinical presentation of the disease, threefold elevation
of the lipase in blood and typical signs on visual
diagnostics. Ultrasound scans for detection of gall-
stone disease, fluid collections, plain chest and
abdominal X-ray were routinely used at admission
and during the treatment course. Initial severity
assessment was done after clinical evaluation,
APACHE II scoring, evidence of SIRS and/or organ
dysfunction at admission. SIRS was diagnosed if two
or more of the following conditions were detected: (a)
temperature above 388C or below 368C; (b) heart rate
above 90 beats/min; (c) respiratory rate above 20
breath/min; or arterial carbon dioxide tension below
32 mmHg; and (d) white blood cell count above
12,000/mm3 or below 4000/mm3, or immature
(band) forms accounting for more than 10% of
neutrophils present [5]. The intensive care specialist
was asked to assess patients with initially suspected
SAP for transfer to the intensive care unit (ICU). SAP
was classified according to the Atlanta 1992 criteria
[6]. Severe manifestation of the disease was consid-
ered when the clinical picture, threefold elevation of
serum lipase accompanied by persistent SIRS and/or
organ dysfunction, and CRP150 mg/day during the
first 48 hours of initial treatment were recognised.
Organ dysfunction was defined according to the
recommendations of the Consensus Conference of
American College of Chest Physicians/Society of
Critical Care medicine in 1991 [7,8]. A MODS was
diagnosed if dysfunction of more than one organ was
detected, requiring intervention to maintain home-
ostasis. SOFA score was calculated for daily assess-
ment of the dynamics of the organ dysfunction [8].
Intra-abdominal pressure (IAP) measurement was
done indirectly through the urinary bladder [9] from
year 2000 as part of the ICU treatment protocol. IAH
was considered when IAP exceeded 12 mmHg
according to the World Society Abdominal Compart-
ment Syndrome definition [10].
Diagnosis of necrotising SAP was based on the
clinical picture supported by the radiological evidence
of pancreatic necrosis and/or involvement of the
peripancreatic tissue on the contrast-enhanced CT
scan considering the period of at least 96 hours after
the onset of the disease. First contrast-enhanced CT
scan was postponed until the patient was transferred
from ICU to the surgical department when the
clinical diagnosis of SAP was evident and conservative
treatment was effective. Repeated contrast-enhanced
CT scan was performed in cases of suspected infection
or clinical deterioration. Early contrast-enhanced CT
scan was performed for differential diagnosis with
other acute surgical pathology. In some cases diag-
nosis was proved during the operation when early
surgical intervention was performed. The presence of
infection was suspected when signs of sepsis and
clinical deterioration with negative dynamics of the
organ dysfunction were evident and proved by con-
trast-enhanced CT scan. Incidence of septic complica-
tions was analysed considering the possible way of
contamination of the necrotic tissue and/or peripan-
creatic fluid. Two types of peripancreatic infections were
defined  infection of necrotic tissue and peripancreatic
fluid collections prior to surgery and infection after early
surgery. Sepsis with positive blood cultures and
patients who demonstrated signs of infection being
admitted within the second phase of the disease were
analysed separately.
Procalcitonin test was implemented since year
2005. Fine needle aspiration and bacterial culture of
the aspirate were not used on routine basis.
Success rate of the conservative or the surgical
treatment was compared in two periods  period 1
from 1999 to 2002 and period 2 from 2003 to 2006.
Frequency of the ventilatory support, pneumonia,
pleural exudate, pulmonary and/or renal dysfunction,
IAH, and infection rate were recorded in both
periods. The number of surgical interventions, overall
ICU, hospital stay, and mortality was analysed.
Treatment protocol
SAP treatment protocol was accepted by hospital
administration and the local ethics commission, and
patients were informed about the procedures and the
associated risks and complications. Initial treatment
consisted of fluid replacement including colloids to
achieve isovolemic haemodilution and organ support
[11]. All patients who were treated only by means of
conservative therapy received early oral feeding
(EOF) with whole protein enteral formula as part of
treatment protocol when gastroenteric transit was not
severely impaired. Initial oral feeding was started with
20 ml bolus of enteral formula every two hours as a
test feeding in patients who explicitly accepted the
feeding protocol and were able to cooperate in the
treatment procedure. The feeding rate was advanced
according to individual tolerance by 20 ml bolus feeds
every hour with further increase of the feeding
volume. The initially employed feed was nutritionally
complete, low fat, whole protein formulas containing
1 kcal/ml (Nutrison Standard or Nutricomp). We did
not follow the principle of the ‘‘goal feeding’’ but
rather the principle ‘‘to feed the gut’’. In more
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complicated cases jejunal or gastric tube feeding was
applied and complemented with parenteral nutrition
and specially adapted formulas when indicated. Par-
enteral nutrition was not used when enteral or oral
feeding was commenced in 35 days and the clinical
course improved.
The main indications for application of CVVH were
progression of SIRS, abdominal compartment syn-
drome (IAP20 mmHg) and persistence of MODS
despite complex initial 2448 hour intensive therapy.
CVVH parameters  haemofiltration (HF) was
performed using Diapact continuous renal replace-
ment therapies (CRRT) from B.Braun Co or Frese-
nius Medical Care Multifiltrate machines, Germany.
The substitution fluid was infused at the rate of 1000
ml/h in pre-diluted or post-diluted manner, compris-
ing 2435 l of total substitute in 24 hours. The blood
flow ranged within 50200 ml/min. Ultra filtration
rate was controlled depending on diuresis and fluid
balance. Haemodiafiltration was provided in accor-
dance with individual indications. Antibiotic prophy-
laxis was used for patients with severely compromised
tissue perfusion, early progressive MODS, sustained
increase of the IAP and signs of cholangitis. The
indication for early surgical intervention was mainly
deterioration of the clinical course despite initial
conservative treatment, progression of abdominal
compartment syndrome (ACS) and obscure diagnosis
on admission. Infection was the main indication for
surgery after the second week and later.
Statistics
Statistical comparison was performed with paired
samples T-test. Clinical data were expressed as
average9standard deviation. Correlation data were
calculated using Pearson’s and Spearman’s Correla-
tion test. Data analysis was performed with SPSS
software version 11.0 (SPSS Inc.).
Results
A total of 274 patients were included in our retro-
spective review, with their age ranging from 19 to 84
years. Male to female ratio was 2.8:1. The main
aetiologic factor was alcohol in 54%, predominantly
in male patients, and gallstone disease in 19%,
predominantly in female patients. Four patients
developed SAP in association with abdominal trauma.
Significant hyperlipidemia was observed in some
patients; however, it was related to fat meal and/or
alcohol consumption in most cases. Average
APACHE II score on admission was 7.494.29 and
8.295.57 in period 1 and period 2, respectively. One
hundred and thirty-two patients suffered SAP without
evident necrosis. Necrotising SAP was recognised in
142 patients with increased incidence during the years
20032006. Systemic inflammatory response as a
pathophysiologic consequence of SAP developed
with similar incidence through both periods in 93
96% of patients. CRP  the biochemical marker of
SIRS had typical dynamics in both periods with the
average peak value on day 3 after admission and
decline on day 7; however, significantly higher average
CRP was observed on admission in period 2, p0.018
(Figure 1 and Table II). Impairment of the organ
function with involvement of at least two organ
systems defined as MODS complicated the clinical
course in 8590% of patients (Table I). Dynamics of
the organ dysfunction according to SOFA score
resembled that of CRP; however, significantly higher
average values were observed on admission, p0.011,
and on day 3, p0.008, in period 2 (Figure 2 and
Table II). Majority of patients were treated in ICU,
though it was accepted as a clinical routine only in
period 2. About half of the patients received ICU
treatment directly from the day of admission more
frequently in period 2 (Table I).
Antibiotic prophylaxis was provided when severe
disturbances of the visceral perfusion were evident,
and when multiple localisations of the inflammatory
Figure 1. Dynamics of CRP.
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fluid collections, signs of early pulmonary, renal
dysfunction, and significant elevation of IAP were
diagnosed during the first 24 hours from hospitalisa-
tion. Ciprofloxacin combination with Metronidasol or
Imipenem/Cilastin was used as an initial antibacterial
therapy. Patients with signs of sepsis and cholangitis
received antibacterial treatment routinely. The mode
of early enteral feeding changed from predominantly
jejunal tube feeding in the period 1 to early oral in
period 2. Tube feeding including nasogastric way was
used mainly in patients who needed longer nutritional
support. Combined enteral and parenteral nutrition
was considered in patients with severe catabolism and
limited possibilities to provide adequate enteral nutri-
tion.
Interventional therapy included drainage of the
larger peripancreatic, retroperitoneal or free abdom-
inal inflammatory exudate collections under ultra-
sound guidance for the temporary control of sepsis or
IAH. Endoscopic sphincterotomy was performed in
patients with progressive cholangitis and mechanical
jaundice. Implementation of the SAP treatment pro-
tocol resulted in more routine early application of the
CVVH in the period 2 comprising 87% vs. 25% in
period 1, pB0.005 (Table III). Correlation analysis did
not reveal interrelation between CVVH and infection
therefore proving safety of the procedure.
More cases of IAH were detected in period 1, pB
0.01 including IAP corresponding to Grade III with
significant difference for Grade IIIIV, pB0.028 and
ACS, pB0.028 (Table III). Positive interrelation was
observed between IAH and incidence of MODS, r
0.188, pB0.002. IAH Grade IIIIV positively
interrelated with the frequency of surgical treatment
(r0.196, pB0.001) and negatively interrelated
with application of conservative treatment only (r
0.196, pB0.001).
Implementation of the SAP treatment protocol was
associated with significant increase in the recognition
of pulmonary complications. Incidence of the re-
vealed pleural exudates and pneumonia increased in
the second period, pB0.005; pB0.001. At the same
time, the number of atelectasis and incidence of
pulmonary dysfunction according to SOFA score
criteria were not statistically different on admission
or later comparing both periods. Ventilatory support
Table I. Epidemiology and severity of the disease.
Total 19992002 20032006
SAP, No. of patients 274 160 114
Mean age (years) 47914.92 49915.76 44913.12
Age range (years) 1984 1984 1979
Male/female, No. /ratio 202/72/2.8: 1




Time from onset (average days/hours) 2.592.43/65.0961.18
Edematous SAP, No. of patients (%) 132 84 (53%) 48 (42%)
Necrotising SAP, No. of patients (%) 142 76 (48%) 66 (58%)
APACHE II score on admission 7.494.29 8.295.57
SIRS, No. of cases (%) 148 (93%) 109 (96%)
MODS, No. of cases (%) 136 (85%) 103 (90%)
ICU treatment 79% 100%
ICU treatment from admission 48% 56%
Figure 2. Dynamics of SOFA.
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was applied in 5% of patients during the first period
and in 8% during period 2 (Table IV). Correlation
analysis revealed that pleural effusion and pulmonary
dysfunction positively interrelated with SIRS through-
out the whole period, r0.142, pB0.019; r
0.19, pB0.002. Pulmonary complications including
atelectasis, pulmonary dysfunction and pneumonia
were also in positive interrelation with IAP, r
0.154, pB0.001; r0.178, pB0.003; r0.143,
pB0.018. Pleural effusion positively interrelated with
application of CVVH, r0.393, pB0.005.
Renal dysfunction was observed equally frequently
in both periods at the time of admission and later
during the treatment course despite the fact that more
necrotising forms characterised period 2 (Table IV).
The Protocol treatment had an impact on the
infection structure. Incidence of infection associated
with drains and catheters due to early surgical or
interventional therapy in the first period was signifi-
cantly higher than cases of infection of necrotic tissue and
peripancreatic fluid collections prior to surgery comprising
38% vs. 3%, pB0.001.This disproportion changed in
the second period when infection after early surgery
decreased to the level of infection of necrotic tissue and
peripancreatic fluid collections prior to surgery equally
comprising 11%. The more conservative approach
resulted in the decrease of the overall infection rate
from 41% in period 1 vs. 21% in period 2, pB0.005
(Table IV) and accordingly in a decreased number of
surgical interventions from 41 to 19%, pB0.001
(Table VI).
Enterococci, Staphylococcus epidermidis, Kleb-
siella pneumoniae, Pseudomonas aeruginosa, Acin-
teobacter baumanii, Escherichia coli and
Stenotrophonoma maltophilia were most often found
in the positive cultures retrieved from the infected
pancreatic and peripancreatic tissue. S. epidermidis,
K. pneumoniae, Enterococci and E. coli were a more
frequent finding in positive blood culture (Table V).
Successes of the conservative treatment signifi-
cantly increased in period 2, when 69% of patients
were discharged without any surgical intervention
compared to 47% in period 1, pB0.01. As a con-
sequence, formation of more postnecrotic pseudo-
cysts was observed in the period 2, pB0.05. Although
surgical treatment in period 2 was associated with
relative but not significant increase in mortality, as
most operations were done in patients with infected
necrosis, the overall mortality rate had a tendency to
decrease reaching 19% for the whole period. The
best treatment results were achieved in year 2006
when overall mortality dropped to 12%. The relatively
longer ICU stay in period 2 was related to a sizable
increase of the necrotising forms compared to period 1.
However, successful results of the conservative
treatment and selective indications for surgical inter-
ventions resulted in shorter hospital stay with reduc-
tion from average of 25.0923.2 days in period 1
to 23.6921.0 days in period 2 and decreased the
overall mortality rate reaching 18% in period 2
compared to 21% in period 1 (main outcomes are
shown in Table VI).
Discussion
Management of acute pancreatitis continues to be an
important medical issue due to the changing but not
improving environment, ethiopathologic conse-
quences of increasing incidence of gallstone disease,
increased alcohol consumption, overweight with
Table II. CRP and SOFA score.
Admission Day 3 Day 7 Day14 Discharge
Average CRP, mg/l
19992002 102983.68 1859110.21 96968.85 67963.10 42951.35
20032006 1839146.44 2639122.87 141963.08 88967.70 48953.01
P 0.018 NS NS NS NS
SOFA score, points
19992002 2.591,59 2.191.61 0.891.19 0.390.46 0
20032006 3.692.62 3.792.61 1.492.00 1.291.75 0
P 0.011 0.008 NS NS NS





CVVH procedure (No. of
patients, %)
40 (25%) 99 (87%) B0.005
IAH all cases (No. of
patients, %)
49 (31%) 16 (14%) B0.01
IAH Grade III (No. of
patients, %)
30 (19%) 11 (10%) NS
IAH Grade IIIIV (No. of
patients, %)
19 (12%) 5 (4%) 0.028




IAH: MODS 0.188 0.002
IAH: Atelectasis 0.154 0.001
IAH: Pulmonary dysfunction 0.178 0.003
IAH: Pneumonia 0.143 0.018
IAH Grade IIIIV: Conservative
treatment
0.196 0.001
IAH Grade IIIIV: Surgical
treatment
0.196 0.001
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hypertrigliceridaemia and other factors predisposing
to disease. At the same time, the number of recent
international SAP management guidelines highlighted
main aspects of the treatment strategy applicable in
General Surgery and Intensive Care setting of the
multiprofile hospital. The aim of our study was
analysis of the recent eight-year experience in the
treatment of SAP in our institution, which belongs to
the above-mentioned category of hospitals.
The main improvement of the treatment results was
achieved following internationally accepted recom-
mendations; however, some aspects of the manage-
ment were different and will be discussed.
The main aetiologic factor in our patients was
alcohol and gallstone disease in a proportion close
to what is reported in the European survey from
Hungary [12]. A more focussed assessment and
growing experience could account for the increasing
number of patients with necrotising SAP admitted in
the last period; however, further studies should be
performed towards recognition of the main tendency.
The natural course of the disease was similar to that
described in the international literature [13] although
CRP  marker of the acute inflammatory response
reached peak values on average three days after the
start of the treatment and had typical decline
approaching day 7. Dynamics of the organ dysfunc-
tion calculated according to the SOFA score were
close to that of CRP. Relatively higher peak values of
both CRP and SOFA score were observed in the
second period when more necrotising forms were
treated supporting our previous experience [14]. Our
data gives some optimism regarding the possibility of
achieving positive treatment results even later than
after 48-hour period from the onset of the disease
when complex ICU treatment and monitoring are
Table V. Bacterial flora.
Species Positive cultures, No. of isolates (%) Species Positive cultures, No. of isolates (%)
Enterococcus 20 57 Staphylococcus hominis 1 3
Staphylococcus epidermidis 12 34 Moraxella lacunata 1 3
Klebsiella pneumoniae 7 20 Pseudomonas putida 1 3
Pseudomonas aeruginosa 6 17 Candida tropicans 1 3
Acinteobacter baumanii 5 14 Candida albicans 1 3
E. coli 4 11 Gemella morbillorum 1 3
Stenotrophomona maltophilia 4 11 MRSA 1 3
Staphylococcus aureus 3 9 Streptococcus oralis 1 3
Staphylococcus xylosus 2 6 Citrobacter 1 3
Enterobacter cloacae 2 6 Acinetobacter Iwoffii 1 3
Positive blood cultures
Staphylococcus epidermidis 9 64 Staphylococcus chromogenes 1 7
Klebsiella pneumoniae 2 14 Candida lipolytica 1 7
Enterococcus 2 14 Enterobacter cloacae 1 7
E. coli 2 14 Enterococcus cancerogenus 1 7
Criptococcus humicolus 1 7 MRSA 1 7
Acinteobacter baumanii 1 7 Staphylococcus aureus 1 7
Candida albicans 1 7
Table IV. Complications.
19992002 20032006 P
Ventilatory support, No. of patients (%) 8 (5%) 9 (8%)
Pulmonary dysfunction, No. of patients (%) 72 (45%) 41 (36%) NS
On admission 15 (9%) 10 (9%) NS
Later 57 (36%) 31 (27%) NS
Atelectasis, No. of patients (%) 10 (6%) 6 (5%) NS
Pleural effusion, No. of patients (%) 41 (26%) 65 (57%) B0.005
Pneumonia, No. of patients (%) 16 (10%) 32 (28%) B0.001
Renal dysfunction, No. of patients (%) 45 (28%) 37 (33%) NS
On admission 11 (7%) 10 (9%) NS
Later 34 (21%) 27 (24%) NS
Infection
Infection, No. of patients (%) 66 (41%) 24 (21%) B0.005
Infection of necrotic tissue and peripancreatic fluid
collections prior to surgery, No. of patients (%)
5 (3%) 12 (11%) 0.01
Infection after early surgery, No. of patients (%) 61 (38%) 12 (11%) B0.005
Admitted with infection Four patients
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provided from admission day. Experience collected in
the second period completely support evidence that
ICU management is advisable for SAP patients as
early as possible [15]. Although the widely discussed
antibiotic prophylaxis is not recommended in some of
recent international publications [1618] majority of
patients with severe course of the disease received
initial antibiotic prophylaxis with Ciprinol and Me-
tronidasol or Imipenem/Cilastin. Further antibacterial
therapy was routinely corrected according to the
cultured microorganism. More selective indications
for antibiotic prophylaxis were applied in the recent
period, with main focus on the derangement of the
tissue perfusion, multiple localisations of the exudate,
early organ dysfunction and IAH.
Protocol treatment had an impact on the infection
structure. The overall infection rate was in the
internationally reported range [15,19]. At the same
time, infection associated with drains and catheters
due to early surgical or interventional therapy drama-
tically decreased in the second period after imple-
mentation of the protocol and more selective surgical
strategy. As a result, the second period demonstrated
a considerably lower infection rate.
We observed predominance of the Gram-positive
flora (Enterococci, S. epidermidis) isolated from the
infected pancreatic and peripancreatic necrotic tissue
followed by Enterobacteriacea (K. pneumoniae, E. coli)
and nonfermenters (P. aeruginosa, A. baumanii, Steno-
trophomona maltophilia). Our finding resembles re-
cently reported observations from Germany [20].
Nutritional support is one of the major constituents
of the conservative therapy protocol. We completely
agree with evidence-based recommendation that ent-
eral feeding should be preferred whenever possible
[21,22]. Jejunal and gastric feeding could be success-
fully applied in cases when tube feeding is indicated
[23]. Recently, we have introduced the mode of EOF
and it is a clinical routine in our Surgical and ICU
Departments [24]. To our knowledge, other authors
do not report similar experience.
CVVH is another treatment modality included on
routine basis in our SAP management protocol.
Implementation of the CVVH was started since year
1999 and at the present moment our experience
covers over 150 patients who underwent early
CVVH due to severe clinical course of acute pancrea-
titis. Authors from China share their experience with
application of mainly high flux CVVH in the treat-
ment of SAP [2528]. Blood purification therapy as a
grade C recommendation is included in acute pan-
creatitis management strategy guidelines from Japan
[29]. Prevention and treatment of the IAH, pulmon-
ary and renal dysfunction as a consequence of
progressive SIRS and MODS were the main indica-
tions for application of early low flux CVVH in our
series [30].
Measurement of the IAP through the urinary
bladder was started in parallel with implementation
of the CVVH. Accuracy of the IAP measurements
increased when all recommendations regarding the
correct measurement technique were followed [9].
This method can be safely used for monitoring of SAP
patients and in combination with SOFA scoring;
biochemical markers of SIRS and infection (Il-6,
CRP, Procalcitonin test) are reliable severity predic-
tors [31] and can reflect effectiveness of the con-
servative therapy.
Early recognition and prevention of systemic com-
plications are essential determinants for favorable
outcome. High incidence of pulmonary complications
early during the clinical course of SAP is well
recognised [32,33]. Pulmonary complications posi-
tively correlated with SIRS and IAH in our series,
confirming tight pathophysiologic relationship.
Stricter adherence to SAP management principles
improved diagnostic accuracy of pulmonary compli-
cations. Incidence of revealed pleural exudates and
pneumonia increased in the second period. Prompt
pulmonary support is of great importance in the
maintenance of the pulmonary function. Despite the
fact that more necrotising forms were associated with
increased incidence of pneumonia and pleural exu-
dates, it did not increase the rate of pulmonary
dysfunction in the second period. Recognition of the
IAH and balanced fluid replacement therapy with
support of CVVH resulted in relatively low need for
ventilatory support. Compared to the data from the
international reviews [34,35] considerably fewer pa-
tients were managed on ventilatory support in our
Table VI. Main outcomes.
19992002 20032006 P
Hospital stay (days) 25.0923.15 23.6921.04 NS
ICU stay (days) 8.9913.05 10.5911.19 NS
Conservative treatment successful, No. of patients (%) 75 (47%) 79 (69%) B0.01
Postnecrotic pseudocysts, No. of patients (%) 11 (7%) 15 (13%) B0.05
Operations, No. of patients (%) 66 (41%) 22 (19%) 0.001
Mortality
Postoperative 21% 32%
Conservative treatment 20% 14%
Overall, No. of patients (%) 33 (21%) 20 (18%) NS
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series. Positive correlation between pleural exudate
and application of CVVH indirectly supported evi-
dence that the procedure was done in patients with
marked SIRS. On the other side, lack of correlation
between CVVH and infection demonstrates the safety
aspect of the procedure.
Effective conservative treatment consequently re-
sulted in significantly decreased number of surgical
interventions in the second period demonstrating
even higher success rate compared to recently re-
ported data [19]. Formation of postnecrotic pseudo-
cysts was a natural outcome in patients with
necrotising pancreatitis. We observed a relatively
higher rate of formation of pseudocysts than pre-
viously reported [36]. The new treatment strategy was
associated with insignificant increase in average ICU
stay in the second period, when more patients with
necrotising forms were treated; however, it did not
prolong but rather decreased the average hospital stay.
Finally, progress with the more conservative approach
resulted in a tendency towards decrease in the overall
mortality rate. Main outcomes in our series are well
comparable with internationally reported data
[15,37,38].
Conclusion
Well-designed SAP treatment protocol is a rational
way how to implement international experience ran-
ging from high volume centres to a multi-profile
hospital setting. Early focused assessment towards
recognition of potentially severe clinical forms of
acute pancreatitis at admission gives additional
chance for favorable outcome even in cases when
more than 48 hours have passed from the onset of the
disease. Commencement of the initial resuscitation
therapy, organ support and monitoring of the physio-
logic response including measurements of the IAP is
recommended to provide in ICU setting. Early
application of CVVH in order to prevent development
or progress of organ dysfunction and IAH could be
rational in patients with marked SIRS. Timely recog-
nition and prevention of pulmonary complications is
essential due its high incidence in SAP. Selective
approach for antibacterial prophylaxis and application
of the interventional therapy are important conditions
for prevention of infection and control of sepsis. EOF
is feasible and effective and can be provided in
majority of SAP patients.
Conservative protocol-based approach is a rational
treatment strategy for the management of SAP and
can be successfully implemented in the setting of the
university hospital. Further studies are needed for
better understanding of the physiologic response,
selective application of interventional therapies and
control of sepsis.
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